Two Sigma Investments’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.3K | Buy |
+12,889
| New | +$64.3K | ﹤0.01% | 2998 |
|
|
2022
Q2 | – | Sell |
-25
| Closed | -$51K | – | 2436 |
|
|
2022
Q1 | $51K | Sell |
25
-78
| -76% | -$159K | ﹤0.01% | 2446 |
|
|
2021
Q4 | $503K | Sell |
103
-151
| -59% | -$737K | ﹤0.01% | 1983 |
|
|
2021
Q3 | $1.6M | Sell |
254
-140
| -36% | -$881K | ﹤0.01% | 1473 |
|
|
2021
Q2 | $3.71M | Buy |
394
+158
| +67% | +$1.49M | 0.01% | 1044 |
|
|
2021
Q1 | $2.05M | Buy |
236
+71
| +43% | +$618K | 0.01% | 1256 |
|
|
2020
Q4 | $1.25M | Sell |
165
-40
| -20% | -$303K | ﹤0.01% | 1254 |
|
|
2020
Q3 | $1.35M | Buy |
205
+115
| +128% | +$755K | ﹤0.01% | 1070 |
|
|
2020
Q2 | $672K | Buy |
+90
| New | +$672K | ﹤0.01% | 1306 |
|